Research Article
BibTex RIS Cite
Year 2024, Volume: 49 Issue: 1, 1 - 18, 26.03.2024
https://doi.org/10.55262/fabadeczacilik.1340872

Abstract

References

  • Alicea-Velázquez, N.L., & Boggon, T.J. (2011). TheUse of Structural Biology in Janus Kinase Targeted Drug Discovery. Current Drug Targets, 12(4), 546- 555. doi: 10.2174/138945011794751528
  • Andraos, R., Qian, Z., Bonenfant, D., Rubert, J., Vangrevelinghe, E., Scheufler, C., Marque, F., Régnier, C. H., De Pover, A., Ryckelynck, H., Bhagwat, N., Koppikar, P., Goel, A., Wyder, L., Tavares, G., Baffert, F., Pissot-Soldermann, C., Manley, P. W., Gaul, C., Voshol, H., & Radimerski, T. (2012). Modulation of Activation-Loop Phosphorylation by JAK Inhibitors Is Binding Mode Dependent. Cancer Discovery, 2(6), 512- 523. doi: 10.1158/2159-8290.CD-11-0324

In Silico Target Prediction Of 6-Gingerol And Similar Compounds As Potential Anticancer Agents

Year 2024, Volume: 49 Issue: 1, 1 - 18, 26.03.2024
https://doi.org/10.55262/fabadeczacilik.1340872

Abstract

Ginger (Zingiber officinale Roscoe) has been widely recognized for its culinary and medicinal applications; however, its potential anticancer activity remains understudied. This research aimed to identify novel lead compounds exhibiting high bioavailability and low toxicity, akin to 6-gingerol, through an in silico screening approach using ChemMine Tools depending on the PubChem fingerprints. The screened compounds were further analyzed using target fishing servers to identify putative kinase targets. Molecular docking studies were conducted on selected kinases including BRAF, JAK1/2, ERK1(MAPK3), and p38γ. Computational analysis was performed to evaluate the pharmacokinetics, drug-likeness, and toxicity profiles of the compounds, shedding light on their safety and bioavailability. Notably, the following compounds exhibited promising anticancer potential: 6-gingerol, vanylglycol, vanillylmandelic acid, L-(+)-vanilmandelic acid, dehydrozingerone, 2-methoxyestrone, methylvanillate, dihydroconiferyl aldehyde, pratensein, acetovanillone, acetosyringone, licochalcone B, isoferulic acid, curcumin PE, and coniferaldehyde. These findings suggest that these compounds warrant further investigation as potential candidates for anti-cancer therapies and should be considered for future lead optimization studies.

References

  • Alicea-Velázquez, N.L., & Boggon, T.J. (2011). TheUse of Structural Biology in Janus Kinase Targeted Drug Discovery. Current Drug Targets, 12(4), 546- 555. doi: 10.2174/138945011794751528
  • Andraos, R., Qian, Z., Bonenfant, D., Rubert, J., Vangrevelinghe, E., Scheufler, C., Marque, F., Régnier, C. H., De Pover, A., Ryckelynck, H., Bhagwat, N., Koppikar, P., Goel, A., Wyder, L., Tavares, G., Baffert, F., Pissot-Soldermann, C., Manley, P. W., Gaul, C., Voshol, H., & Radimerski, T. (2012). Modulation of Activation-Loop Phosphorylation by JAK Inhibitors Is Binding Mode Dependent. Cancer Discovery, 2(6), 512- 523. doi: 10.1158/2159-8290.CD-11-0324
There are 2 citations in total.

Details

Primary Language English
Subjects Pharmaceutical Chemistry
Journal Section Research Article
Authors

Nour Osama Al-massrı 0009-0004-8699-3003

Enise Ece Gurdal 0000-0003-1064-8639

Gulcin Tugcu 0000-0002-9750-6563

Publication Date March 26, 2024
Submission Date August 15, 2023
Published in Issue Year 2024 Volume: 49 Issue: 1

Cite

APA Al-massrı, N. O., Gurdal, E. E., & Tugcu, G. (2024). In Silico Target Prediction Of 6-Gingerol And Similar Compounds As Potential Anticancer Agents. Fabad Eczacılık Bilimler Dergisi, 49(1), 1-18. https://doi.org/10.55262/fabadeczacilik.1340872